Insider Transactions in Q4 2023 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2023
|
Christopher Krawtschuk Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,526
-9.05%
|
$18,104
$4.52 P/Share
|
|
Nov 03
2023
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
807
-0.28%
|
$2,421
$3.17 P/Share
|
|
Nov 02
2023
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,343
-1.83%
|
$4,686
$2.98 P/Share
|